Injectable Targets Décolleté Wrinkles - Takeaways - MDSpire

Injectable Targets Décolleté Wrinkles

New indication expands use of injectable biostimulator beyond the face.

  • By

  • Kathryn Wighton

  • April 10, 2026

  • 2 min

Share

  • 1

    The FDA has approved RADIESSE for treating décolleté wrinkles in patients aged 22 and older.

  • 2

    RADIESSE acts as a biostimulator, promoting collagen and elastin production with effects lasting up to 2 years.

  • 3

    Over 80% of patients reported satisfaction with skin tightness after RADIESSE treatment.

  • 4

    Adverse events may include bruising, swelling, and serious complications from unintentional intravascular injection.

  • 5

    RADIESSE is not recommended for patients with allergies to its components or specific health conditions.

Original Source(s)

Injectable Targets Décolleté Wrinkles

  • by Kathryn Wighton

  • April 10, 2026

Related Content

Consensus Guidelines for Dermocosmetic Ingredient Selection in Common Dermatological Situations in Egypt: A RAND/UCLA Appropriateness Assessment

Cosmetic outcomes of oncoplastic surgeries in breast cancer patients: an eleven-year experience from two tertiary referral centers

Kiwifruit's Effect on Skin Examined 

Pilot study links 8 weeks of daily consumption to increased epidermal proliferation in patients with low baseline ascorbate